about
Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditionsDatasets of genes coexpressed with FBN1 in mouse adipose tissue and during human adipogenesis.Progress on the HUPO Draft Human Proteome: 2017 Metrics of the Human Proteome Project.Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis.Interorgan Communication Pathways in Physiology: Focus on Drosophila.Regulation of hepatic glucose metabolism in health and disease.Expanded Normal Weight Obesity and Insulin Resistance in US Adults of the National Health and Nutrition Examination Survey.Adipose tissue in 2016: Advances in the understanding of adipose tissue biology.Fell-Muir Lecture: Fibrillin microfibrils: structural tensometers of elastic tissues?LTBPs in biology and medicine: LTBP diseases.Asprosin is a centrally acting orexigenic hormone.Microfluidic systems for studying dynamic function of adipocytes and adipose tissue.Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit.Control of (pre)-analytical aspects in immunoassay measurements of metabolic hormones in rodents.Microfibril-associated glycoproteins MAGP-1 and MAGP-2 in disease.Wiedemann-Rautenstrauch syndrome: A phenotype analysis.Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice.Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion.A Spotlight on AppetiteNew hormone regulates glucose
P2860
Q34533265-08A0CEBC-2514-4A93-9247-2748D71F5F39Q34536904-3DC79ABF-4651-4A0D-B395-43D8C5B48641Q38602346-8C910B88-7E27-407D-AAAD-3B28A8423AF0Q38765909-5B1FA563-CB2C-4FEC-A515-0956556CB1C4Q38812346-5EC54566-F6BA-45B4-AFC8-66FB7A77A0E3Q39450184-0E14E882-F013-4341-941E-E0C0D69637F2Q41294306-98AABDA6-A2AE-4F31-A50E-E877A1D4FFAEQ41811198-424E8045-E4BD-48D2-95DE-900F9FF29A00Q42376279-05A9C297-B291-4841-89F3-F0F74970F763Q47318255-65857DFA-02E9-47F6-B31F-739971A6F3DDQ47438181-351EC9CF-3B53-41F4-B0CB-C1D89D42EF44Q47796012-99D9B8F5-3B33-4EE5-9BB6-3BFFDC30118DQ52431634-4D02FFA6-C9F7-4036-8656-5DB5D61494B7Q52655500-226EB4F3-A192-4DED-B691-F43124253C79Q52727442-C4D07D1C-2BA6-4486-91AC-1E76ED0117F1Q52944262-12C5692E-978D-4409-BC13-84E4AAD8C284Q55049564-17DDFFB0-34EE-4D0E-8879-80005F672848Q55078266-E403D826-9F77-4820-956A-D81B52CDC581Q58001983-87C38E08-8957-4FCF-8269-C0648A7467D9Q74439031-FBE471C4-C7EA-4A7A-9E5B-C339AD6960C4
P2860
description
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2016
@ast
im April 2016 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2016/04/21)
@sk
vědecký článek publikovaný v roce 2016
@cs
wetenschappelijk artikel (gepubliceerd op 2016/04/21)
@nl
наукова стаття, опублікована у квітні 2016
@uk
مقالة علمية (نشرت في 21-4-2016)
@ar
name
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
@ast
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
@en
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
@nl
type
label
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
@ast
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
@en
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
@nl
prefLabel
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
@ast
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
@en
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
@nl
P2093
P2860
P50
P3181
P1433
P1476
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
@en
P2093
Atul R Chopra
Brian York
Chase Romere
David A Rendon
David D Moore
Dianna M Milewicz
Joseph S Coselli
Juan Bournat
Mahim Jain
P2860
P304
P3181
P356
10.1016/J.CELL.2016.02.063
P407
P577
2016-04-14T00:00:00Z